IMOPHORON
Imophoron is the developer of a novel next-generation rapid-response vaccine platform, ADDomer(TM).
IMOPHORON
Industry:
Biotechnology Life Science Therapeutics
Founded:
2017-01-01
Address:
Bristol, Bristol, City Of, United Kingdom
Country:
United Kingdom
Total Employee:
1+
Status:
Active
Total Funding:
4 M GBP
Similar Organizations
ATAI Life Sciences
ATAI Life Sciences develops innovative mental health treatments that address significant unmet medical needs.
Autobahn Therapeutics
Autobahn Therapeutics is a developer of regenerative medicines to restore hope for people affected by CNS disorders.
Menten AI
Menten AI develops peptide and protein therapeutics using machine learning and quantum computing.
Slingshot Biosciences
Slingshot Biosciences develops next-generation synthetic cells for diagnostics and therapeutics.
Current Employees Featured
Harry Destecroix
Harry Destecroix Non Executive Director @ Imophoron Non Executive Director 2021-11-01
Frederic Garzoni
Frederic Garzoni CEO, Co-founder, and Director @ Imophoron CEO, Co-founder, and Director
Founder
Frederic Garzoni
Investors List
Science Creates Ventures
Science Creates Ventures investment in Seed Round - Imophoron
Jonathan Milner
Jonathan Milner investment in Seed Round - Imophoron
Octopus Ventures
Octopus Ventures investment in Seed Round - Imophoron